GK01 Injection
GK01 Injection is a pharmaceutical drug with 6 clinical trials. Currently 3 active trials ongoing.
Success Metrics
Phase Distribution
Phase Distribution
6
Early Stage
0
Mid Stage
0
Late Stage
Highest Phase Reached
Phase 1Trial Status & Enrollment
0.0%
0 of 0 finished
0.0%
0 ended early
3
trials recruiting
6
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
A Clinical Study GK01 Cell Injection in Subjects With Advanced Lung Cancer
A Clinical Study GK01 Cell Injection in Subjects With Advanced Solid Tumors.
A Clinical Study GK01 Injection in Subjects With Advanced Malignant Solid Tumors
A Single-Arm, Open-Label Clinical Study GK01 Cell Injection in Subjects With Advanced Solid Tumors.
A Single-arm, Open-label Study of GK01 in Combination With or Without Chemotherapy for the Adjuvant Treatment of Solid Tumors
Clinical Trials (6)
A Clinical Study GK01 Cell Injection in Subjects With Advanced Lung Cancer
A Clinical Study GK01 Cell Injection in Subjects With Advanced Solid Tumors.
A Clinical Study GK01 Injection in Subjects With Advanced Malignant Solid Tumors
A Single-Arm, Open-Label Clinical Study GK01 Cell Injection in Subjects With Advanced Solid Tumors.
A Single-arm, Open-label Study of GK01 in Combination With or Without Chemotherapy for the Adjuvant Treatment of Solid Tumors
A Single-Arm, Open-Label, Phase I Study of GK01 for Advanced Solid Tumor
All 6 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 6